Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapid Micro-Induction vs Standard Induction of Buprenorphine/Naloxone for OUD
NCT04234191Phase 2Recruiting
- Sponsor
- University of British Columbia
- Start
- Aug 2021
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of buprenorphine + naloxone in opioid use disorder (OUD), sponsored by University of British Columbia. Started Aug 2021; status: recruiting.
02
Drugs
buprenorphine + naloxone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT04234191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04234191.